Moderna's avian flu vaccine contract canceled by HHS amid ongoing debates about mRNA technology safety and effectiveness.

The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.

Discover how lab-grown bat organoids and cell lines are revolutionizing virus research and pandemic preparedness worldwide.

Cocrystal Pharma, Inc. (Nasdaq: COCP) ("Cocrystal” or the "Company”) announces that management will participate in a fireside chat during the Noble Capital Markets' 2025 Emerging Growth Virtual Equity ...

Kobedi Pilane, CEO of African Poultry Producers and a commercial poultry farmer in Brakfontein, near Parys in North West, ...

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB. Explore delivery mechanisms, key technologies, and future breakthroughs.

A powerful account of Ojibwe leaders Chief Blackstone and his son Bakindeghiizhik. A family legacy of challenging narratives and defending Anishinaabe rights.

Recce Pharmaceuticals (ASX: RCE) has received a Notice of Acceptance from the China National Intellectual Property ...

The Gs/Gd lineage of highly pathogenic H5 avian influenza viruses—including H5N1—has rapidly evolved, spreading globally and ...

Flu shots save lives across the United States every year. These vaccines are good at protecting the population from severe ...

Apr. 22, 2025 — A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment.

Over the past three years, avian influenza (H5N1) has spread around the U.S. and affected many species of birds and mammals, ...